Bullet-proofing Brexit
Despite all the doom and gloom, Brexit isn’t a big deal when it comes to finance, writes Ranjeet Singh of London Stone Securities.
Despite all the doom and gloom, Brexit isn’t a big deal when it comes to finance, writes Ranjeet Singh of London Stone Securities.
Tissue Regenix saw sales for the six months ended 30th June rise by 61% to £5.6 million with gross margins up by 12.1 percentage points to 56%.
Shares in AIM-listed shoes and streetwear retailer Footasylum plunged by 50% to 42p after there was no recovery on the UK high street performance.
FTSE 250 veterinary drug manufacturer Dechra Pharmaceuticals announced that revenues for the first six months of the year rose by 13.3% to £407.1 million.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
AIM-listed EMIS saw its shares rise by 3.83% to 950p after first-half revenues climbed by 7% to £84.5 million and reported profits rose by 23%.
Rathbone Brothers has announced that it has completed the acquisition of Speirs & Jeffrey after the receipt of FCA approval.
FTSE 100 hospitality operator Whitbread has agreed the sale of its Costa Coffee brand to The Coca Cola Company for an enterprise value of £3.9 billion.
Simon Cawkwell, AKA Evil Knievil, with his latest trading and gambling exploits – writing exclusively for Master Investor.
Mrs May has been visiting the three largest economies in Africa this week – South Africa, Nigeria and Kenya. These countries, it seems, are part of Britain’s post-Brexit strategy of becoming a global trading power. Victor Hill asks: What’s behind the new scramble for Africa?